GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embla Medical hf (OCSE:EMBLA) » Definitions » Return-on-Tangible-Asset

Embla Medical hf (OCSE:EMBLA) Return-on-Tangible-Asset : 12.83% (As of Sep. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Embla Medical hf Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Embla Medical hf's annualized Net Income for the quarter that ended in Sep. 2024 was kr588 Mil. Embla Medical hf's average total tangible assets for the quarter that ended in Sep. 2024 was kr4,580 Mil. Therefore, Embla Medical hf's annualized Return-on-Tangible-Asset for the quarter that ended in Sep. 2024 was 12.83%.

The historical rank and industry rank for Embla Medical hf's Return-on-Tangible-Asset or its related term are showing as below:

OCSE:EMBLA' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 1.13   Med: 16.18   Max: 24.53
Current: 10.68

During the past 13 years, Embla Medical hf's highest Return-on-Tangible-Asset was 24.53%. The lowest was 1.13%. And the median was 16.18%.

OCSE:EMBLA's Return-on-Tangible-Asset is ranked better than
86.87% of 868 companies
in the Medical Devices & Instruments industry
Industry Median: -2.435 vs OCSE:EMBLA: 10.68

Embla Medical hf Return-on-Tangible-Asset Historical Data

The historical data trend for Embla Medical hf's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embla Medical hf Return-on-Tangible-Asset Chart

Embla Medical hf Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.33 1.13 12.21 7.78 9.51

Embla Medical hf Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.38 12.28 5.17 12.16 12.83

Competitive Comparison of Embla Medical hf's Return-on-Tangible-Asset

For the Medical Devices subindustry, Embla Medical hf's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Embla Medical hf's Return-on-Tangible-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Embla Medical hf's Return-on-Tangible-Asset falls into.



Embla Medical hf Return-on-Tangible-Asset Calculation

Embla Medical hf's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=399.077/( (4094.056+4298.993)/ 2 )
=399.077/4196.5245
=9.51 %

Embla Medical hf's annualized Return-on-Tangible-Asset for the quarter that ended in Sep. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Sep. 2024 )  (Q: Jun. 2024 )(Q: Sep. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Sep. 2024 )  (Q: Jun. 2024 )(Q: Sep. 2024 )
=587.504/( (4633.905+4526.642)/ 2 )
=587.504/4580.2735
=12.83 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Sep. 2024) net income data.


Embla Medical hf  (OCSE:EMBLA) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Embla Medical hf Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Embla Medical hf's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Embla Medical hf Business Description

Traded in Other Exchanges
Address
Grjothals 5, Reykjavik, ISL
Embla Medical hf is a provider of prosthetics and bracing and supports solutions; FIOR & GENTZ, an innovative developer of neuro orthotics; and College Park, creators of custom-built prosthetic solutions for people of all activity levels..

Embla Medical hf Headlines

No Headlines